Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-010184
Filing Date
2023-02-16
Accepted
2023-02-16 17:26:42
Documents
2
Period of Report
2023-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6436
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4337
  Complete submission text file 0001209191-23-010184.txt   12169
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, FLOOR 14 NEW HAVEN CT 06510
Business Address
Simon Farrell (Reporting) CIK: 0001965585 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38886 | Film No.: 23639483